Literature DB >> 34907769

A novel upper tract ureteroscopic biopsy technique: the "form tackle".

Dane E Klett1, Manaf Alom1, Kevin Wymer1, Aaron Potretzke1.   

Abstract

INTRODUCTION AND
OBJECTIVE: Upper tract urothelial carcinoma (UTUC) represents 5% of all urothelial malignancies (1-3). Accurate pathologic diagnosis is key and may direct treatment decisions. Current ureteroscopic biopsy techniques include cold-cup, backloaded cold-cup and stone basket (4-6). The study objective was to compare a standard cold-cup biopsy technique to a novel cold-cup biopsy technique and evaluate histopathologic results.
MATERIALS AND METHODS: We developed a novel UTUC biopsy technique termed the "form tackle" biopsy. Ureteroscope is passed into ureter/renal collecting system. Cold-cup forceps are opened and pressed into the lesion base (to engage the urothelial wall/submucosal tissue) then closed. Ureteroscope/forceps are advanced forward 3-10mm and then extracted from the patient. We compared standard versus novel upper tract biopsy techniques in a series of patients with lesions ≥1cm. In each procedure, two standard and two novel biopsies were obtained from the same lesion. The primary study aim was diagnosis of malignancy. IRB approved: 21-006907.
RESULTS: Fourteen procedures performed on 12 patients between June 2020 and March 2021. Twenty-eight specimens sent (14 standard, 14 novel) (Two biopsies per specimen). Ten procedures with concordant pathology. In 4 procedures the novel biopsy technique resulted in a diagnosis of UTUC (2 high-grade, 2 low-grade) in the setting of a benign standard biopsy. Significant difference in pathologic diagnoses was detected between standard and novel upper tract biopsy techniques (p=0.008).
CONCLUSIONS: The "form tackle" upper tract ureteroscopic biopsy technique provides higher tissue yield which may increase diagnostic accuracy. Further study on additional patients required. Early results are encouraging. Copyright® by the International Brazilian Journal of Urology.

Entities:  

Mesh:

Year:  2022        PMID: 34907769      PMCID: PMC8932032          DOI: 10.1590/S1677-5538.IBJU.2021.0499

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  6 in total

1.  Comparison of biopsy devices in upper tract urothelial carcinoma.

Authors:  Alberto Breda; Angelo Territo; Francesco Sanguedolce; Giuseppe Basile; Jose D Subiela; Helena Vila Reyes; Olga Mayordomo Ferrer; Jose M Gaya; Joan Palou
Journal:  World J Urol       Date:  2018-12-17       Impact factor: 4.226

2.  Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps.

Authors:  Nir Kleinmann; Kelly A Healy; Scott G Hubosky; David Margel; Marluce Bibbo; Demetrius H Bagley
Journal:  J Endourol       Date:  2013-11-19       Impact factor: 2.942

3.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

Review 4.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard J Sylvester; Maximilian Burger; Nigel C Cowan; Paolo Gontero; Bas W G Van Rhijn; A Hugh Mostafid; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2017-09-01       Impact factor: 20.096

5.  Multi-institutional Evaluation of Upper Urinary Tract Biopsy Using Backloaded Cup Biopsy Forceps, a Nitinol Basket, and Standard Cup Biopsy Forceps.

Authors:  Daniel J Lama; Shoaib Safiullah; Roshan M Patel; Thomas K Lee; Jyoti P Balani; Lishi Zhang; Zhamshid Okhunov; Vitaly Margulis; Stephen J Savage; Edward Uchio; Jaime Landman
Journal:  Urology       Date:  2018-04-06       Impact factor: 2.649

Review 6.  Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis.

Authors:  Gopal Sharma; Anuj Kumar Yadav; Tarun Pareek; Pawan Kaundal; Shantanu Tyagi; Sudheer Kumar Devana; Shrawan Kumar Singh
Journal:  Int Braz J Urol       Date:  2022 May-Jun       Impact factor: 3.050

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.